Avoro Capital Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

Avoro Capital Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,775,000	Closed	-$229M	–	48
2024 Q1	$229M	Buy	+5,775,000	New	+$170M	2.67%	15

Avoro Capital Advisors's ALPN Position: Q2 2024 in Review

Avoro Capital Advisors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 5,775,000 shares — an estimated $229M sold.

Avoro Capital Advisors first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $229M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Avoro Capital Advisors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Avoro Capital Advisors sold 5,775,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $229M.
Avoro Capital Advisors first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Avoro Capital Advisors's Alpine Immune Sciences Inc position peaked at $229M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Avoro Capital Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.